APRISO Rx

Select the drug indication to add to your list

APRISO

Colorectal disorders
Only 4 drugs may be compared at once

Generic Name and Formulations:

Mesalamine 0.375g; ext-rel caps; contains phenylalanine 0.56mg/cap.

Select therapeutic use:

Indications for APRISO:

Maintenance of remission of ulcerative colitis (UC) in adults.

Adult:

≥18yrs: 1.5g once daily in the AM.

Children:

<18yrs: not established.

Warnings/Precautions:

Sulfasalazine allergy. Renal dysfunction or history of renal disease; assess renal function at the beginning and periodically during treatment. Hepatic impairment. Elderly (monitor CBCs). Pregnancy (Cat.B). Nursing mothers.

Interactions:

Do not co-administer with antacids.

Pharmacological Class:

Aminosalicylate.

Adverse Reactions:

Headache, nausea, diarrhea, upper abdominal pain, nasopharyngitis, flu-like symptoms, sinusitis; renal impairment, mesalamine-induced acute intolerance syndrome (eg, cramping, abdominal pain, bloody diarrhea, fever, headache, rash); discontinue if occurs.

Generic Availability:

NO

How Supplied:

Caps—120

APRISO 0.375g capsules (Qty:120)

appx. price $460.00